Filtres: Autor és Guinó, E [Clear All Filters]
No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations. British journal of cancer. 2011;104(4):735-40.
Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review. PloS one. 2012;7(11):e48877.
Tools for protein-protein interaction network analysis in cancer research. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2012;14(1):3-14.
Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2013;15(4):414-22.
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS biology. 2011;9(11):e1001199.
Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. European journal of cancer (Oxford, England : 1990). 2008;44(9):1229-37.
Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. European journal of cancer (Oxford, England : 1990). 2007;43(4):762-8.
SNPassoc: an R package to perform whole genome association studies. Bioinformatics (Oxford, England). 2007;23(5):644-5.
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration. The pharmacogenomics journal. 2012.
Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. Clinical chemistry. 2008;54(7):1132-40.
Allele-specific expression of APC in adenomatous polyposis families. Gastroenterology. 2010;139(2):439-7, 447.e1.
Participation rates in the selection of population controls in a case-control study of colorectal cancer using two recruitment methods. Gaceta sanitaria / S.E.S.P.A.S. 2011;25(5):353-6.
Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. European journal of human genetics : EJHG. 2012.